Spero Emerges with $3M, Backing from Roche, and Plans to Disarm Bugs Posted on April 9, 2014 at 1:02 am.Written by Spero Therapeutics Post navigation Pushing Forward with Collaborative R&D Models in BiotechSpero Therapeutics Catches Roche’s Eye with a New Way to Target Drug-Resistant Bacterial Infections
